Levels of insulin-like growth factor-1 (IGF-1) are substantially elevated and more bioactive in the milk of cows hyperstimulated with the biosynthetic bovine growth hormones rBGH, and are further increased by pasteurization. IGF-1 is absorbed from the gastrointestinal tract, as evidenced by marked growth-promoting effects even in short-term tests in mature rats, and absorption is likely to be still higher in infants. Converging lines of evidence incriminate IGF-1 in rBGH milk as a potential risk factor for both breast and gastrointestinal cancers.
Get full access to this article
View all access options for this article.
References
1.
PesteringS. S.Potential Public Health Hazards of Biosynthetic Milk Hormones. Letter and report to FDA Commissioner Frank Young, July 19, 1989.
2.
EpsteinS. S.Potential public health hazards of biosynthetic milk hormones. Int. J. Health Serv. 20: 73–84, 1990.
3.
EpsteinS. S.Questions and answers on synthetic bovine growth hormones. Int. J. Health Serv. 20: 573–581, 1990.
4.
Food and Drug Administration. Interim guidance on the voluntary labelling of milk and milk products from cows that have not been treated with recombinant bovine somatotropin. Federal Register59(28): 6279–6280, 1994.
5.
EpsteinS. S.A needless new risk of breast cancer (commentary). Los Angeles Times, March 20, 1994, p. M5.
6.
MatthewsI. S.NorstedtG.PalmiterR. D.Regulation of insulin-like growth factor I gene expression by growth hormone. Proc. Natl. Acad. Sci. USA83: 9343–9347, 1986.
7.
Sekyi-OtuA.Metastatic behavior of the RIF-1 murine fibrosarcoma: Inhibited by hypophysectomy and partially restored by growth hormone replacement. J. Natl. Cancer Inst. 86: 628–632, 1994.
8.
IsgaardJ.Pulsatile intravenous growth hormone (GH) infusion to hypophysectomized rats increases insulin-like growth factor I messenger ribonucleic acid in skeletal tissues more effectively than continuous GH infusion. Endocrinology123: 2605–2610, 1988.
9.
HoneggerA.HumbelR. R.Insulin-like growth factors I and II in fetal and adult bovine serum. J. Biol. Chem.261: 569–575, 1986.
10.
McBrideB. W.BurtonJ. L.BurtonJ. H.The influence of bovine growth hormone (somatotropin) on animals and their products. Res. Dev. Agricult.5: 1–21, 1988.
11.
ProsserC. G.Changes in concentration of insulin-like growth factor I (IGF-1) in milk during bovine growth hormone treatment in the goat. J. Endocrinol.112(March Suppl.), Abstr. 65, 1987.
12.
ProsserC. G.Bovine somatotropin and milk composition. Lancet1: 1201, November 19, 1988.
13.
ProsserC. G.FleetI. R.CorpsA. N.Increased secretion of insulin-like growth factor I into milk of cows treated with recombinantly derived bovine growth hormone. J. Dairy Res. 56: 17–26, 1989.
14.
MephamT. B.Public health implications of bovine somatotropin use in dairying: Discussion paper. J. R. Soc. Med.85: 736–739, 1992.
FrystykJ.Free insulin-like growth factors (IGF-1 and IGF-II) in human serum. FEBS Lett. 348: 185–191, 1994.
17.
HansenM. K.Biotechnology and Milk: Benefit or Threat?, p. 6. Consumer Policy Institute, New York, 1990.
18.
SchamsD.Secretion of somatotropin and IGF-1 into milk during BST administration. In Sometribove: Mechanism of Action, Safety and Instructions for Use. Monsanto, Basingstoke, 1991.
19.
MephamT. B.Safety of milk from cows treated with bovine somatotropin. Lancet2: 197, 1994.
20.
National Institutes of Health. Technology Assessment Conference Statement on Bovine Somatotropin. JAMA265: 1423–1425, 1991.
21.
DaughadayW. H.KapadiaM.MarizI.Serum somatomedin binding proteins: Physiologic significance and interference in radioligand assay. J. Lab. Clin. Med.109: 355–363, 1987.
22.
MesianoS.Failure of acid-ethanol treatment to prevent interference by binding proteins in radioligand assays for the insulin-like growth factors. J. Endocrinol.119: 453–460, 1988.
23.
FrancisG. L.Insulin-like growth factors 1 and 2 in bovine colostrum—Sequences and biological activities compared with those of a potent truncated form. Biochem. J.251: 95–103, 1988.
LevinskyR. J.Factors influencing uptake of food antigens. Proc. Nutr. Soc.44: 81–86, 1985.
26.
RobertonD. M., Milk antigen absorption in the preterm and term neonate. Arch. Dis. Child.57: 369–372, 1982.
27.
ReinhardtM. C.Molecular absorption of food antigens in health and disease. Ann. Allergy53: 597–601, 1984.
28.
UdallJ. N.Human digestion and absorption of milk and its components at different stages of development: Protein hormones and growth factors. In NIH Technology Assessment Conference, Bovine Somatotropin, pp. 91–97. Bethesda, Md., 1990.
29.
LeeE. J.HeinerC.Allergy to cow's milk—1984. Pediatr. Rev.7: 195–203, 1986.
30.
TeskeR. H., Center for Veterinary Medicine FDA. Letter to S. Epstein, March 7, 1994, in response to Epstein's February 14, 1994, letter to FDA Commissioner Dr. Kessler.
31.
FAO/WHO, Expert Committee on Food Additives. Evaluation of certain veterinary drug remedies in food. WHO Tech. Rep. Ser.832, 4/5, pp. 113–142, 1992.
32.
CollierR. J.Qualitative and quantitative changes in hormones and growth factors in milk as affected by the administration of rBST to cattle. In NIH Technology Assessment Conference, pp. 45–49. Bethesda, Md., 1994.
33.
HammondB., Manager, Toxicology, Monsanto Agriculture Co. Letter to Jerry Elliott, Program Analyst, Office of Medical Applications of Research, NIH, December 19, 1990.
34.
HansenM. K.Letter to FDA, May 24, 1993.
35.
EpsteinS. S.Polluted data. The Sciences18: 16–21, 1978.
36.
CarverP., Staff Director to Rep. D. Obey, D-Wis., House Subcommittee on Labor, Health and Human Services. Personal communication, May 30, 1994.
37.
ArmstrongJ. D.(Hoffman-LaRoche/Monsanto). Effects of sometribove or immunization against growth hormone releasing factor (GRFi) on milk yield and composition, calf gain, insulin and metabolites in multiparous beef cows. J. Dairy Sci. 77(Suppl. 1): 182, 1994.
38.
GlimmD. R.BaracosV. E.KennellyJ. J.Effect of bovine somatotropin on the distribution of immunoreactive insulin-like growth factor-1 in lactating bovine mammary tissue. J. Dairy Sci. 71: 2923–2935, 1988.
39.
FurlanettoR. W.DiCarloJ. N.Somatomedin-C receptors and growth effects in human breast cells maintained in long-term tissue culture. Cancer Res. 44: 2122–2128, 1984.
40.
GregorP.BurleighB. D.Presence of high affinity somatomedin/insulin-like growth factor receptors in porcine mammary gland. Endocrinology116(Suppl. 1), Abstr.223, 1985.
41.
CampbellP. G.BaumruckerC. R.Characterization of insulin-like growth factor-1/somatomedin-C receptors in bovine mammary gland. J. Dairy Sci. 69(Suppl. 1), Abstr. 163, 1986.
42.
UllrichA.SchessingerJ.Signal transduction by receptors with tyrosine-kinase activity. Cell61: 203–212, 1990.
43.
LippmanM. E.The development of biological therapies for breast cancer. Science259: 631–632, 1993.
44.
PappaV.Insulin-like growth factor-1 receptors are overexpressed and predict a low risk in human breast cancer. Cancer Res. 53: 3736–3740, 1993.
45.
ReynoldsR. K.Regulation of epidermal growth factor and insulin-like growth factor I receptors by estradiol and progesterone in normal and neoplastic endometrial cell cultures. Gynecol. Oncol.38(3): 396–406, 1990.
46.
RechlerM. M.NissleyS. P.The nature and regulation of the receptors for insulin-like growth factor. Annu. Rev. Physiol.47: 425–442, 1985.
47.
OsborneC. K.ClemmonsD. R.ArteagaC. L.Regulation of breast cancer growth by insulin-like growth factors. J. Steroid Biochem. Mol. Biol.37: 805–809, 1990.
48.
RosenN.Insulin-like growth factors in human breast cancer. Breast Cancer Res. Treat.18(Suppl.): 555–562, 1991.
49.
PollakM. N.HuynhH. T.LefebvreP.Tamoxifen reduces insulin-like growth factor I (IGF-1). Breast Cancer Res. Treat.22: 91–100, 1992.
50.
BaxterR. C.High molecular weight somatomedin-C/IGF-1 from T47D human mammary carcinoma cells: Immunoreactivity and bioactivity. In Insulin-like Growth Factors/Somatomedins: Basic Chemistry, Biology, Clinical Importance, edited by SpencerE. M., pp. 615–618. DeGruyter, New York, 1983.
51.
HuffK. K.Secretion of an insulin-like growth factor-1-related protein by human breast cancer cells. Cancer Res. 46: 4618–4619, 1986.
52.
HarrisJ. R.Breast cancer. N. Engl. J. Med.7: 473–4180, 1992.
53.
LippmanM.Growth factors, receptors and breast cancer. J. Natl. Inst. Health Res. 3: 59–62, 1991.
54.
EkbomA.Evidence of prenatal influence on breast cancer risk. Lancet, October 24, 1992, pp. 1015–1018.
55.
EpsteinS. S.Environmental and occupational pollutants are avoidable causes of breast cancer. Int. J. Health Serv. 24: 145–159, 1994.
56.
ElwoodJ. M.CoxB.RichardsonA. K.The effectiveness of breast cancer screening by mammography in younger women. Online J. Current Clin. Trials193, No. 32, 1993.
57.
CorpsA. R.BrownK. D., Stimulation of intestinal epithelial cell proliferation in culture by growth factors in human and ruminant mammary secretions. J. Endocrinol.113: 285–290, 1987.
58.
PlayfordR. J.Effect of luminal growth factor preservation on intestinal growth. Lancet2: 843–848, 1993.
59.
ChaurasiaO. P.Insulin-like growth factor I in human gastrointestinal exocrine secretions. Regul. Pept.50: 113–119, 1994.
60.
OlanrewajuH.PatelL.SiedelE. R.Trophic action of local intraileal infusion of insulin-like growth factor 1: Polyamine dependence. Am. J. Physiol.263: E282–E286, 1992.
61.
ChallacombeD. N.WheelerE. E.Safety of milk from cows treated with bovine somatotropin. Lancer344: 815–816, 1994.
62.
CoghlanD.Arguing till the cows come home. New Scientist, October 26, 1994, pp. 11–12.
63.
LahmH.Growth regulation and co-stimulation of human colorectal cancer cell lines by insulin-like growth factor I, II and transforming growth factor alpha. Br. J. Cancer65(3): 341–346, 1992.
64.
GuoY. S.Insulinlike growth factor-binding protein modulates the growth response to insulinlike growth factor 1 by human gastric cancer cells. Gastroenterology104(6): 1595–1604, 1993.
65.
BurtonJ. L.A review of bovine growth hormone. Can. J. Animal Sci. 74: 167–201, 1994.
66.
American Medical Association Council on Scientific Affairs. Biotechnology and the American agricultural industry. JAMA265: 1429–1436, 1991.
